NANOVIRICIDES, INC. Current Assets
NANOVIRICIDES, INC. (NNVC) had Current Assets of $3.38 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-05-15
- 2026-03-31: Assets, Current $3.38M.
- 2025-12-31: Assets, Current $5.30M.
- 2025-09-30: Assets, Current $1.25M.
- 2025-06-30: Assets, Current $1.67M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $3.38M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.30M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.67M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $2.73M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $4.07M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $4.04M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.97M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $3.52M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $5.32M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $7.14M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.45M 10-K · filed 2024-09-27 | |
| 2023-03-31 | $9.93M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.55M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $13.15M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $14.42M 10-K · filed 2023-10-13 | |
| 2022-03-31 | $15.95M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $17.52M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $19.89M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $20.82M 10-K · filed 2022-10-13 | |
| 2021-03-31 | $23.23M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $18.49M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $22.02M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $13.99M 10-K · filed 2021-10-12 | |
| 2020-03-31 | $6.44M 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $1.35M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.34M 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $2.83M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $4.63M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $4.07M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $6.28M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $7.32M 10-K · filed 2019-08-23 | |
| 2018-03-31 | $10.95M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $12.29M 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $13.70M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $15.29M 10-K · filed 2018-10-12 | |
| 2017-03-31 | $16.74M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $19.44M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $22.12M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $24.38M 10-K · filed 2017-09-28 | |
| 2016-03-31 | $25.91M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $28.34M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $29.64M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $31.68M 10-K · filed 2016-09-16 | |
| 2015-03-31 | $34.29M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $35.49M 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $41.60M 10-Q/A · filed 2015-02-23 | |
| 2014-06-30 | $36.95M 10-K · filed 2015-09-14 | $37.66M 10-K · filed 2014-09-30 |
| 2014-03-31 | $34.60M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $17.76M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $20.01M 10-Q/A · filed 2015-02-23 | |
| 2013-06-30 | $14.52M 10-K · filed 2015-02-23 | |
| 2013-03-31 | $17.00M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $14.68M 10-Q/A · filed 2013-02-22 | |
| 2012-09-30 | $13.37M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $14.59M 10-K/A · filed 2013-10-08 | |
| 2012-03-31 | $13.28M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $12.42M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $11.20M 10-Q/A · filed 2011-12-12 | |
| 2011-06-30 | $9.56M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |